Literature DB >> 34759205

Ultrasound-Enhanced Transcorneal Drug Delivery for Treatment of Fungal Keratitis.

Claire Allison1, Blake Cellum1, Bianca Karpinecz1, Fadi Nasrallah2, Vesna Zderic1.   

Abstract

PURPOSE: Transcorneal drug delivery is hindered by ocular physical and biochemical properties, such as tear production, the epithelial layer of the cornea, and blinking. The aim of this study was to determine whether ultrasound can be applied to increase the transcorneal drug delivery of natamycin used in the treatment of fungal keratitis without dangerously overheating the surrounding ocular tissues.
METHODS: To verify the safety of various sets of ultrasound parameters, modeling studies were conducted using OnScale, an ultrasonic wave modeling software. Ultrasound parameters determined optimal for ocular tissue safety were used in a laboratory setting in a jacketed Franz diffusion cell setup. Histological images of the cross-section of the corneas used in experiments were examined for cell damage under a microscope.
RESULTS: Increases in transcorneal drug delivery were seen in every treatment parameter combination when compared with the sham treatment. The highest increase was 4.0 times for 5 minutes of pulsed ultrasound at a 25% duty cycle and a frequency of 400 kHz and an intensity of 0.5 W/cm 2 with statistical significance ( P < 0.001). Histological analysis revealed structural damage only in the corneal epithelium, with most damage being at the epithelial surface.
CONCLUSIONS: This study suggests that ultrasound is a safe, effective, and minimally invasive treatment method for enhancing the transcorneal drug delivery of natamycin. Further research is needed into the long-term effects of ultrasound parameters used in this study on human ocular tissues.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34759205     DOI: 10.1097/ICO.0000000000002916

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

Review 1.  Making waves: how ultrasound-targeted drug delivery is changing pharmaceutical approaches.

Authors:  Lauren J Delaney; Selin Isguven; John R Eisenbrey; Noreen J Hickok; Flemming Forsberg
Journal:  Mater Adv       Date:  2022-02-23

2.  Therapeutic Ultrasound for Topical Corneal Delivery of Macromolecules.

Authors:  Hanaa H Almogbil; Felipe Montecinos-Franjola; Camille Daszynski; William J Conlon; Justin S Hachey; Giavanna Corazza; Erik A Rodriguez; Vesna Zderic
Journal:  Transl Vis Sci Technol       Date:  2022-08-01       Impact factor: 3.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.